Cure Today

Will There Be a Resurgence of Ki-67 Scoring in Breast Cancer?

An FDA approval put Ki-67 scoring — which may predict tumor growth — in the spotlight, but what that means long term to patients depends on who you ask. The speed at which cancer cells grow can be an ...
Nature

Ki 67 is a major, but not the sole determinant of Oncotype Dx recurrence score

Immunohistological assessment of Ki 67 expression is less expensive than Oncotype Dx, which is currently used to identify patients with lymph node-negative breast cancer, who will benefit from ...
ascopubs.org

Is proliferative index (Ki-67) useful to stratify patients (pts) with G2 gastroenteropancreatic neuroendocrine tumors (GEP-NETs)? Clinicopathologic correlation.

Significance of serum interleukin-6 in patients treated with radiotherapy for hepatocellular carcinoma. This is an ASCO Meeting Abstract from the 2015 Gastrointestinal Cancers Symposium. This abstract ...
ascopubs.org

Is proliferative index (Ki 67) useful to stratify patients (pts) with G2 gastro-entero-pancreatic neuroendocrine tumors (GEP-NETs)? Clinicopathologic correlation.

Treatment outcomes of patients with mixed adenoneuroendocrine carcinoma (MANEC). This is an ASCO Meeting Abstract from the 2015 ASCO Annual Meeting I. This abstract does not include a full text ...